Source:http://linkedlifedata.com/resource/pubmed/id/20091113
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-3-1
|
pubmed:abstractText |
Individuals vary in their subjective responses to stimulant drugs, and these differences are believed to be partially genetic in origin. We evaluated associations between mood, cognitive and cardiovascular responses to d-amphetamine and four polymorphisms in the dopamine transporter (SLC6A3): rs460000, rs3756450, rs37022 and rs6869645. Healthy Caucasian male and female volunteers (N = 152) participated in a double-blind, crossover design study in which they received placebo, 10 and 20 mg of d-amphetamine. We measured self-reported rating of mood, performance on the Digit Symbol Substitution Task, blood pressure and heart rate. Individuals with the C/C genotype at rs460000 (N = 83) reported approximately twofold higher ratings of stimulation and euphoria relative to the A/A+A/C (N = 69) genotype group, at both the 10 and 20 mg doses. No other responses or SNPs showed significant effects. rs460000 is in perfect LD with rs463379 (CEU: D' = 1; r (2) = 1), which was not studied here, but has been associated with etiology of Attention Deficit Hyperactivity Disorder (ADHD). These findings suggest a pleiotropic effect of this polymorphic locus on both ADHD and sensitivity to the subjective effects of amphetamine.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/DA021336,
http://linkedlifedata.com/resource/pubmed/grant/DA024920,
http://linkedlifedata.com/resource/pubmed/grant/DA02812,
http://linkedlifedata.com/resource/pubmed/grant/F32 DA024920-01,
http://linkedlifedata.com/resource/pubmed/grant/F32 DA024920-02,
http://linkedlifedata.com/resource/pubmed/grant/RR00055
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1573-3297
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-61
|
pubmed:dateRevised |
2011-9-22
|
pubmed:meshHeading |
pubmed-meshheading:20091113-Adolescent,
pubmed-meshheading:20091113-Adult,
pubmed-meshheading:20091113-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:20091113-Cross-Over Studies,
pubmed-meshheading:20091113-Dextroamphetamine,
pubmed-meshheading:20091113-Dopamine Plasma Membrane Transport Proteins,
pubmed-meshheading:20091113-Double-Blind Method,
pubmed-meshheading:20091113-Female,
pubmed-meshheading:20091113-Genotype,
pubmed-meshheading:20091113-Humans,
pubmed-meshheading:20091113-Male,
pubmed-meshheading:20091113-Pharmacogenetics,
pubmed-meshheading:20091113-Placebos,
pubmed-meshheading:20091113-Polymorphism, Genetic,
pubmed-meshheading:20091113-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers.
|
pubmed:affiliation |
The University of Chicago, Chicago, IL, USA.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, N.I.H., Extramural
|